Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1309535rdf:typepubmed:Citationlld:pubmed
pubmed-article:1309535lifeskim:mentionsumls-concept:C0600139lld:lifeskim
pubmed-article:1309535lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:1309535lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:1309535lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:1309535lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:1309535pubmed:issue1lld:pubmed
pubmed-article:1309535pubmed:dateCreated1992-2-10lld:pubmed
pubmed-article:1309535pubmed:abstractTextTo develop a new approach to the treatment of advanced, hormone-refractory prostate cancer, the signal transductions regulating the growth of human androgen-independent prostate carcinoma cell lines were studied. Agonist-stimulated Ca2+ mobilization, a critical regulatory event in other secretory cell types, was studied as a means of identifying previously undescribed plasma membrane receptors that may transduce a growth inhibitory signal. In all of the cell lines tested, P2-purinergic receptor agonists, including ATP and certain hydrolysis-resistant adenine nucleotides, induced a rapid, transient increase in cytoplasmic free Ca2+ that was detectable at 50 to 100 nM ATP, was maximal at 100 microM ATP, and was inhibited approximately 50% by chelation of extracellular Ca2+. Within 8 s after addition, ATP stimulated accumulation of the polyphosphatidylinositol products inositol (1, 4, 5) trisphosphate, inositol (1, 3, 4) trisphosphate, and inositol tetrakisphosphate. In addition to stimulating phosphatidylinositol turnover and Ca2+ mobilization, ATP and hydrolysis-resistant ATP analogues induced greater than 90% inhibition of the growth of all lines tested. These data demonstrate that human androgen-independent prostate carcinoma cells express functional P2-purinergic receptors linked to phospholipase C, and that agonists of this receptor are markedly growth inhibitory, suggesting a novel therapeutic approach to this common adult neoplasm.lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:languageenglld:pubmed
pubmed-article:1309535pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1309535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1309535pubmed:statusMEDLINElld:pubmed
pubmed-article:1309535pubmed:monthJanlld:pubmed
pubmed-article:1309535pubmed:issn0021-9738lld:pubmed
pubmed-article:1309535pubmed:authorpubmed-author:MyersC ECElld:pubmed
pubmed-article:1309535pubmed:authorpubmed-author:TrepelJ BJBlld:pubmed
pubmed-article:1309535pubmed:authorpubmed-author:CaseF HFH3rdlld:pubmed
pubmed-article:1309535pubmed:authorpubmed-author:FangW GWGlld:pubmed
pubmed-article:1309535pubmed:authorpubmed-author:PirniaFFlld:pubmed
pubmed-article:1309535pubmed:issnTypePrintlld:pubmed
pubmed-article:1309535pubmed:volume89lld:pubmed
pubmed-article:1309535pubmed:ownerNLMlld:pubmed
pubmed-article:1309535pubmed:authorsCompleteYlld:pubmed
pubmed-article:1309535pubmed:pagination191-6lld:pubmed
pubmed-article:1309535pubmed:dateRevised2010-9-7lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:meshHeadingpubmed-meshheading:1309535-...lld:pubmed
pubmed-article:1309535pubmed:year1992lld:pubmed
pubmed-article:1309535pubmed:articleTitleP2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells.lld:pubmed
pubmed-article:1309535pubmed:affiliationClinical Pharmacology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.lld:pubmed
pubmed-article:1309535pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1309535pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1309535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1309535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1309535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1309535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1309535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1309535lld:pubmed